Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

LOGIN HERE

Cancel

BSE Code : 543904 | NSE Symbol : MANKIND | ISIN : INE634S01028 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Profit and Loss

Particulars (₹ Cr)	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue From Operations	9,264.81	8,127.15	7,486.22	5,523.18	4,794.41
Sale of Products	9,218.55	8,082.54	7,448.21	5,388.89	4,651.89
Sale of Services	45.11	38.04	38.01	97.27	78.26
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	1.15	6.58	0.00	37.02	64.26
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	9,264.81	8,127.15	7,486.22	5,523.18	4,794.41
Other Income	266.64	162.78	203.81	154.50	93.85
Total Revenue	9,531.45	8,289.94	7,690.04	5,677.68	4,888.26
Changes in Inventories	-25.36	267.89	-365.27	-254.25	-44.51
Cost of Material Consumed	861.74	711.05	772.59	494.53	434.87
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	2,071.92	1,865.82	2,114.12	1,541.89	1,182.55
Employee Benefits	1,982.10	1,701.38	1,462.76	1,167.42	991.47
Total Other Expenses	2,049.30	1,883.64	1,663.95	1,201.72	986.57
Manufacturing / Operating Expenses	213.57	175.62	153.93	103.86	104.22
Administrative and Selling Expenses	1,699.55	1,539.07	1,378.52	905.53	696.80
Other Expenses	136.18	168.95	131.50	192.32	185.55
Finance Costs	14.57	27.75	47.12	7.98	10.62
Depreciation and Amortization	317.61	269.58	123.33	78.19	61.77
Total Expenses	7,271.88	6,727.10	5,818.60	4,237.47	3,623.34
Profit Before Exceptional Items and Tax	2,259.57	1,562.84	1,871.44	1,440.21	1,264.92
Exceptional Items Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Extraordinary Items and Tax	2,259.57	1,562.84	1,871.44	1,440.21	1,264.92
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	2,259.57	1,562.84	1,871.44	1,440.21	1,264.92
Taxation	436.16	314.58	482.01	355.83	306.70
Current Tax	415.39	296.00	429.03	346.99	336.58
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	24.18	30.30	52.98	8.84	-35.11
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	-3.41	-11.72	0.00	0.00	5.23
Profit After Tax	1,823.41	1,248.26	1,389.42	1,084.37	958.23
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	1,823.41	1,248.26	1,389.42	1,084.37	958.23
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	1,823.41	1,248.26	1,389.42	1,084.37	958.23
Earning Per Share - Basic	45.52	31.16	34.68	27.07	23.92
Earning Per Share - Diluted	45.45	31.16	34.68	27.07	23.92

LOGIN HERE

LOGIN HERE

Mankind Pharma Ltd

Profit and Loss